MRI-detected extramural vascular invasion (mrEMVI) as the best predictive factor to identify candidates to total neoadjuvant therapy in locally advanced rectal cancer.
Paolo MassuccoAndrea P FontanaAnnalisa Balbo MussettoBenedetta DesanaAndrea RicottiFederica GonellaMichela MinecciaStefano CirilloAlessandro FerreroPublished in: Journal of surgical oncology (2022)
This study confirmed that mrEMVI is a powerful predictor of DM in LARC. It should be routinely reported and considered during multidisciplinary care strategy planning.
Keyphrases
- rectal cancer
- locally advanced
- neoadjuvant chemotherapy
- squamous cell carcinoma
- phase ii study
- radiation therapy
- healthcare
- quality improvement
- magnetic resonance imaging
- contrast enhanced
- type diabetes
- lymph node
- stem cells
- metabolic syndrome
- magnetic resonance
- diffusion weighted imaging
- affordable care act
- mesenchymal stem cells
- glycemic control
- smoking cessation